Jps Health Network
Acute Care Hospitals · Government - Hospital District or Authority
1500 S Main St
Fort Worth, TX 76104
- Emergency services
- Medicare overall rating: 4 of 5 stars
At a glance
- Clinicians who list this hospital
- 794
- Physicians (MD and DO)
- 479
- Residents and fellows in training (full-time equivalents, fiscal year 2024)
- 229
- Medical groups
- 15+
Quality and patient experience
- Medicare overall rating (of 5)
- 4
- Patient survey rating (of 5)
- 3
- Patients who would definitely recommend it (national average 71%)
- 71%
Compared with the national rate
| Measures | Better | Same | Worse |
|---|---|---|---|
| Deaths after treatment | 0 | 6 | 0 |
| Safety of care (infections, complications) | 2 | 4 | 1 |
| Readmissions and return visits | 0 | 7 | 1 |
Number of Medicare quality measures where this hospital’s rate is statistically better than, the same as (no different from), or worse than the national rate.
What patients said
- Doctors communicated well 3 of 5 stars
- Nurses communicated well 3 of 5 stars
- Explained medicines 3 of 5 stars
- Discharge information 3 of 5 stars
- Clean 3 of 5 stars
- Quiet at night 2 of 5 stars
From 2,442 patient surveys (HCAHPS), period ending 09/30/2025.
Medicare “birthing-friendly” hospital: takes part in a maternity care quality program and follows recommended safety practices.
Source: CMS Care Compare (Hospital General Information; Patient survey HCAHPS). Ratings describe the hospital overall, not individual doctors.
Physicians by specialty
- Family Medicine 100
- Internal Medicine 60
- Emergency Medicine 40
- Radiology 33
- Psychiatry 25
- Pathology 16
- Ophthalmology 16
- OB-GYN (Obstetrics & Gynecology) 13
- Nephrology (Kidney) 13
- Urology 13
- General Surgery 11
- Neurology 10
- Anesthesiology 9
- Critical Care Medicine 8
- Orthopedic Surgery 7
- Hospitalist 6
- Sports Medicine 6
- Pulmonology 6
- Infectious Disease 6
- Cardiology 5
- Interventional Radiology 5
- Gastroenterology 5
- Rheumatology 5
- Pain Medicine 4
- Vascular Surgery 4
- Retina Specialist 3
- Hospice & Palliative Medicine 3
- Cardiothoracic Surgery 3
- ENT (Otolaryngology) 3
- Neurosurgery 3
- Endocrinology & Diabetes 3
- Hematology & Oncology 3
- Geriatric Medicine 3
- Medical Oncology 3
- Hand Surgery 2
- Maternal-Fetal Medicine (High-Risk Pregnancy) 2
- Trauma Surgery 2
- Interventional Cardiology 2
- Radiation Oncology 2
- Cardiac Electrophysiology 2
- Physical Medicine & Rehabilitation (PM&R) 2
- Plastic Surgery 2
- Spine Surgery 1
- Urogynecology 1
- Facial Plastic Surgery 1
- Pediatrics 1
- Surgical Oncology 1
- General Practice 1
- Dermatopathology 1
- Dermatology 1
- Gynecologic Oncology 1
Other clinicians
Medical groups whose clinicians work here
- Acclaim Physician Group Inc 473
- Sound Physicians Anesthesiology of Texas PLLC 69
- Hospitalist Medicine Physicians of Texas PLLC 62
- Integrative Emergency Services Physician Group PA 57
- Radiology Associates of North Texas PA 52
- University of Texas Southwestern Medical Center at Dallas 36
- Healthtexas Provider Network 28
- Propath Associates PLLC 18
- Century Integrated PArtners, Inc 16
- Clinical Care in Radiology 10
- Oral and Maxillofacial Network PLLC 7
- Ppg Health PA 6
- Lonestar Hospital Medicine Associates PA 5
- Dialysis Associates 5
- North Texas Toxicology PLLC 4
Number of each group’s clinicians who list this hospital.
Industry-funded research here
Drug and device companies reported $1,239,150 in research payments to this hospital in 2025 for 34 studies.
- A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment …
Novartis Pharmaceuticals Corporation · $282,523 - A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
Eli Lilly and Company · $107,442 · Active, not recruiting - Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
AbbVie Inc. · $97,031 · Active, not recruiting - A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia (ARISE)
E.r. Squibb & Sons, L.l.c. · $83,430 - Efficacy and Safety of Inavolisib Phesgo vs Placebo Phesgo in PIK3CA Mutated HER2 BC
Genentech, Inc. · $76,644 - An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
E.r. Squibb & Sons, L.l.c. · $62,974 - A Phase III Randomized Double blind Multicenter Global Study of Rilvegostomig or Pembrolizumab in Combination with Platinum based Chemotherapy for the First line Treatment of Patients with Metastatic Non squamous Non …
AstraZeneca Pharmaceuticals LP · $55,944 - Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
AbbVie Inc. · $55,922 · Completed - A PHASE 3, TWO-STAGE, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY COMPARING CC-92480 (BMS-986348), CARFILZOMIB AND DEXAMETHASONE (480Kd) VERSUS CARFILZOMIB AND DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED OR REFRACT…
Celgene Corporation · $41,164 - A phase iii, randomized, open-label, multicenter study evaluating the efficacy and safety of divaras
Genentech, Inc. · $37,511 - A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab MK-3475 Versus Treatment of Physician s Choice TPC in Participants With Triple-Negative…
Merck Sharp & Dohme LLC · $34,852 - A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT Sacituzumab Tirumotecan, MK-2870 Followed by Carboplatin,Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neo…
Merck Sharp & Dohme LLC · $34,812
From CMS Open Payments research payments to this hospital as a teaching hospital. Payments to affiliated universities or research foundations are reported under those names. All industry-funded trials →
Other hospitals in the same county
- Texas Health Harris Methodist Fort Worth 1,291
- Baylor Scott and White All Saints Medical Center 686
- Texas Health Harris Methodist Hospital Southwest F 636
- Baylor Scott & White Medical Center Grapevine 634
- Methodist Mansfield Medical Center 499
- Texas Health Huguley Hospital Fort Worth South 482
- Medical City Arlington 451
- Texas Health Arlington Memorial Hospital 436
Sources: CMS Hospital General Information and Doctors and Clinicians Facility Affiliation (Care Compare), CMS certification number 450039. Counts are clinicians who list this hospital with Medicare; they include part-time and visiting clinicians and aren’t staff totals. Residents and beds are from the hospital’s Medicare cost report. Ratings are Medicare’s, not ours.